Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases

Clinical trial NCT07481786 · RECRUITING

Trial details

NCT number: NCT07481786
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Lung Adenocarcinoma Brain Metastases Radiotherapy, Intensity-Modulated Bevacizumab Whole-Brain Radiotherapy

Start date: 2026-03-20
Primary completion: 2029-09-15
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.